P

Pfizer

Makes cancer drugs, vaccines and other medicines

Field Medical Director - Breast and Gynecological Cancers

Full-TimePosted on 10/21/2026Deadline 10/31/26
$230.9k - $384.8k/yr
Mid, Senior
MD
Kansas, USA+3 moreMore locations: Nebraska, USA | Missouri, USA | Illinois, USA
RemoteRemote field-based role; travel 50–75% of the time and weekend congress coverage may be required. Preferred residence in or near Chicago, IL.
Biology & Biotech
No H1B Sponsorship

About the job

Requirements
  • An MD or equivalent is required.
  • Relevant experience is required: MD with 4 years of experience, PhD/PharmD with 5 years, MBA/MS with 7 years, or BA/BSc with 8 years.
  • Be a subject matter expert recognized across internal and external stakeholders.
  • Demonstrate diverse leadership experience and the ability to influence and collaborate with peers and create business impact.
  • Demonstrate clinical and technical skills.
  • Demonstrate oral and written communication skills.
  • Demonstrate interpersonal skills to understand and respond to multiple external and internal customer demands and manage conflict constructively.
  • Demonstrate change agility, flexibility to new opportunities such as new therapeutic areas, and adaptability to organizational change.
  • Manage a significant volume of projects in a remote environment, prioritize and implement them successfully, exercise sound judgment, and work in a continuous-improvement environment.
  • Work within a matrixed, multidisciplinary team to foster professional relationships with Pfizer and customers aligned with Pfizer Medical objectives.
  • Manage and lead change in an evolving external healthcare environment.
  • Problem-solve and network across the enterprise as appropriate to identify solutions.
  • Collaborate effectively and demonstrate leadership and teamwork with peers, internal stakeholders, and external customers to support alignment and partnership on a shared vision or strategy.
  • Be self-starting and accountable, and deliver results with medical impact and a positive customer experience.
  • Maintain self-awareness and choose behaviors and responses based on their impact on personal and others’ performance and engagement.
  • Adopt new digital technology, including artificial intelligence, and use new technologies in routine work and with medical customers.
  • Document all medical interactions in a timely manner as required.
  • Be able to operate a Pfizer company car and regularly fly for customer meetings, medical congresses, and internal company meetings; proximity to an airline hub city is expected.
  • Travel 50–75% of the time.
  • Previous Field Medical experience is preferred.
  • Breast Cancer therapeutic area expertise is preferred.
  • Gynecological Cancers therapeutic area expertise is preferred.
  • Familiarity with internal and external standard operating procedures, rules, and regulations concerning Pfizer/customer interactions and relationships is preferred.
  • Be able to work weekends for congress coverage.
  • Be authorized to work in the United States by any employer; permanent U.S. work authorization is required.
Responsibilities
  • Plan and execute Medical strategy and engagement for appropriate assigned customers within a territory, coordinating compliantly with Pfizer colleagues as needed to achieve Medical objectives.
  • Maintain the required knowledge of relevant therapeutic areas, disease states, and Pfizer medicines, and provide therapeutic area and product information to internal and external stakeholders as needed.
  • Serve as a conduit and resource for Medical Information and customer insights, provide requested information to healthcare professionals as allowed by Pfizer guidance, and share customer viewpoints with Pfizer as appropriate.
  • Understand Pfizer Medical Affairs priorities, contribute to Medical content strategy development, and execute aligned Field Medical tactics.
  • Maintain effective and appropriate communication and collaboration with headquarters Medical colleagues, Medical Information, and other Pfizer Field Medical colleagues.
  • Communicate through live and virtual presentations, written communications, and telephone or virtual conversations in small and large settings.
  • Optimize patient centricity in Medical communications and deliverables by incorporating health literacy and cultural awareness principles.
  • Deliver approved medical content about Pfizer medicines and relevant topics in the designated therapeutic area.
  • Identify and seek medical engagement with priority customer segments in the assigned therapeutic area.
  • Provide truthful, accurate, scientifically supported responses to direct unsolicited medical requests from healthcare professionals in compliance with Pfizer guidelines, policies, and procedures.
  • Manage and provide scientific leadership in a regional territory, collaborating with cross-therapeutic-area field medical colleagues in shared institutions.
  • Contribute to or co-lead virtual advisory boards with manager oversight as appropriate.
  • Field relevant inbound healthcare professional queries through the established triage process.
  • Collaborate with Global Medical Affairs colleagues and partner with Oncology Research & Development and Clinical Operations to identify potential sites for Pfizer-sponsored clinical trials, including sites serving underrepresented patient populations.
  • Provide appropriate Medical support throughout the Investigator Sponsored Research process.
  • Cultivate research and therapeutic area expertise, including familiarity with current congress data and disease-state literature.
  • Provide asset leadership as needed.
  • Understand study design, methodology, data analysis, and interpretation, and communicate these concepts to customers.
  • Communicate reactively and proactively with local Patient Advocacy Groups as appropriate, in close collaboration with Corporate Affairs and headquarters Medical Affairs.
  • Provide insights on local patient organization structure, capabilities, and patient population needs.
  • Serve on Medical and/or therapeutic-area and asset cross-functional committees as appropriate.
  • Represent Pfizer Medical Affairs leadership with clinical/professional associations and societies, demonstrating medical professionalism in all interactions.
  • Mentor through onboarding partnerships and advisory-board and study-lead mentoring as appropriate.
  • Participate in special projects as needed.
  • Collaborate compliantly with commercial colleagues to support practitioner needs.
Desired Qualifications
  • Previous Field Medical experience.
  • Breast Cancer therapeutic area expertise.
  • Gynecological Cancers therapeutic area expertise.
  • Residence in or near Chicago, Illinois.
  • Familiarity with internal and external standard operating procedures, rules, and regulations concerning Pfizer/customer interactions and relationships.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

6 month growth

-4%

1 year growth

-3%

2 year growth

-3%
Yahoo Finance
Oct 22nd, 2026
Pfizer's 5.7% yield signals risk: dividends took 108% of free cash flow vs Merck's 66%

Merck's dividend looks safer than Pfizer's, despite Pfizer's higher yield, according to a 24/7 Wall St. comparison. Pfizer yields about 5.7% against Merck's 2.2%. In 2025, Pfizer's dividends used 108% of free cash flow, while Merck's used 66%. In the first half of 2026, Merck's free cash flow covered 174% of its payout; Pfizer's covered about 51%. Merck has raised its quarterly dividend 39% since 2020, to $0.85. Pfizer's rose 13% and has been flat at $0.43 since January 2025. Pfizer is cheaper, at about 10 times 2026 earnings against Merck's 17. Pfizer targets a return to growth from 2029, while Merck's newer drugs are already selling.

Yahoo Finance
Oct 21st, 2026
Pfizer announces layoffs at Rocky Mount and Sanford sites, but gives no numbers

Pfizer has announced layoffs at its Rocky Mount and Sanford facilities in North Carolina, as part of a push to improve efficiency. It told employees of the cuts on Tuesday but did not say how many jobs will go, when, or in which departments. Rocky Mount makes sterile injectables, while Sanford focuses on vaccines and advanced biologics, including gene therapies. "Headcount reductions are a part of this initiative," Pfizer said, adding that it will give affected staff support services. "If indeed this happens, it's going to affect those families," said David Farris, president and chief executive officer of the Rocky Mount Area Chamber of Commerce. The impact on local economies, he said, depends on the number laid off. As of Wednesday afternoon, no Worker Adjustment and Retraining Notification (WARN) notice had been filed with the state.

Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.